Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Humira Efficacy Response Optimization Study (HERO)
NCT00234897Phase 4Completed
- Sponsor
- Abbott Laboratories
- Start
- Aug 2004
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of Trudexa in rheumatoid arthritis (RA), sponsored by Abbott Laboratories. Started Aug 2004; status: completed.
02
Drugs
Trudexa
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00234897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00234897.